Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations (Q34011740)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations |
scientific article |
Statements
1 reference
Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations (English)
1 reference
Hagop M Kantarjian
1 reference
Zeev Estrov
1 reference
Farhad Ravandi
1 reference
Gautam Borthakur
1 reference
Guillermo Garcia-Manero
1 reference
Marina Konopleva
1 reference
Michael Andreeff
1 reference
Jorge E Cortes
1 reference
Rajyalakshmi Luthra
1 reference
Yesid Alvarado
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference